Guardian Capital LP Biogen Inc. Transaction History

Guardian Capital LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 14, 2018	SELL	$257.52 - $306.91 $345,849 - $412,180	-1,343 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$260.13 - $367.91 $7,803 - $11,037	-30 Reduced 2.18%	1,343 $367,000
Q4 2017 Feb 14, 2018	BUY	$307.64 - $344.58 $155,050 - $173,668	504 Added 58.0%	1,373 $437,000
Q3 2017 Nov 15, 2017	BUY	$281.15 - $329.69 $244,319 - $286,500	869	869 $272,000

1,036

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $22.8B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Guardian Capital LP, based on Form 13F filings with the SEC.

Stay updated on Guardian Capital LP with notifications on news.